MedPath

OXALIPLATIN INJECTION, USP

OXALIPLATIN INJECTION, USP

Approved
DIN Number

02458403

Drug Class

Human

Market Date

Jul 13, 2022

Company
HC

dr reddy's laboratories ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02458403
AIG Number0152220003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XA03 OXALIPLATIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXALIPLATINActive
Strength: 5 MG / ML
Monograph: OXALIPLATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.